Watch Demo

Croatia Antidiabetics Industry Outlook 2024 - 2028

See how Croatia Antidiabetics performed compared to key markets such as Canada, Italy and Australia.

Key Market Indicators

**Croatian Diabetes Medicine Sales to Hit $650 Million by 2028** The Croatian market for diabetes medicines is projected to grow steadily, reaching approximately $650 million by 2028, up from nearly $590 million in 2023. This marks an average annual growth rate of 1.5%. Since 2010, the Croatian market has seen a consistent increase, averaging a 3.4% growth per year. In 2023, Croatia ranked fourth in diabetes medicine sales, following Italy, Australia, and Croatia itself, with Australia surpassing Croatia at around $590 million. **Croatian Insulin Export Set to Surge** Croatian insulin exports are expected to rise significantly, reaching nearly $671,000 by 2028, compared to around $529,000 in 2023. This represents an average annual growth rate of 3.6%. Since 1997, Croatia's insulin supply has increased by an average of 5.3% each year. In 2023, Croatia was ranked 27th in insulin exports, with South Africa taking the leading position at about $529,000. France, Italy, and China were the top three in this ranking. **Insulin Imports to Grow Steadily** Croatia's insulin imports are also on the rise, projected to reach approximately $38.5 million by 2028, up from around $34.1 million in 2023. This indicates an average annual growth rate of 1.8%. Since 1997, the demand for insulin in Croatia has grown by an average of 2.2% per year.

Marketing Banner

Croatia Antidiabetics Market Data and Forecasts

How much will Croatia Antidiabetics Market grow to 2028?

Forecast: Insulin in Dosage Market Size Value in Croatia
Forecast: Import of Insulin in Dosage Forms to Croatia
Forecast: Export of Insulin in Dosage Forms from Croatia
Forecast: Import of Insulin in Dosage Forms to Croatia
Forecast: Diabetes Medicine Sales in Croatia
More in Antidiabetics Industry for 2028